Cargando…

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021

Detalles Bibliográficos
Autores principales: Zambrano, Laura D., Newhams, Margaret M., Olson, Samantha M., Halasa, Natasha B., Price, Ashley M., Boom, Julie A., Sahni, Leila C., Kamidani, Satoshi, Tarquinio, Keiko M., Maddux, Aline B., Heidemann, Sabrina M., Bhumbra, Samina S., Bline, Katherine E., Nofziger, Ryan A., Hobbs, Charlotte V., Bradford, Tamara T., Cvijanovich, Natalie Z., Irby, Katherine, Mack, Elizabeth H., Cullimore, Melissa L., Pannaraj, Pia S., Kong, Michele, Walker, Tracie C., Gertz, Shira J., Michelson, Kelly N., Cameron, Melissa A., Chiotos, Kathleen, Maamari, Mia, Schuster, Jennifer E., Orzel, Amber O., Patel, Manish M., Campbell, Angela P., Randolph, Adrienne G., Murdock, Meghan, Gaspers, Mary Glas, Typpo, Katri V., Kelley, Connor P., Sanders, Ronald C., Yates, Masson, Smith, Chelsea, Crane, Katheryn, Lionetti, Geraldina, Murcia-Montoya, Juliana, Zinter, Matt S., Villarreal-Chico, Denise, Skura, Adam L., Peralta, Harvey, Lockwood, Justin M., Port, Emily, Carson, Imogene A., Chatani, Brandon M., Hussaini, Laila, Baida, Nadine, Coates, Bria M., Rowan, Courtney M., Stumpf, Mary, Johnston, Marla S., Boutselis, Benjamin J., Kucukak, Suden, Chen, Sabrina R., Weller, Edie, Berbert, Laura, He, Jie, Flori, Heidi R., Hume, Janet R., Bruno, Ellen R., Goertzen, Lexie A., Levy, Emily R., Behl, Supriya, Drapeau, Noelle M., Martin, Lora, Malloch, Lacy, Sanders, Cameron, Patterson, Kayla, Dhanrajani, Anita, Hill, Shannon M., Kietzman, Abigail, Rinehart, Valerie H., Hoody, Lauren A., Schwartz, Stephanie P., Navas, Angelo G., Bennett, Paris C., Twinem, Nicole A., Tomcany, Merry L., Staat, Mary Allen, Rohlfs, Chelsea C., Wolfe, Amber, Douglas, Rebecca L., Phengchomphet, Kathlyn, Bickford, Megan M., Wakefield, Lauren E., Smallcomb, Laura, Stewart, Laura S., Golchha, Meena, Oates, Jennifer N., Bowens, Cindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757620/
https://www.ncbi.nlm.nih.gov/pubmed/35025852
http://dx.doi.org/10.15585/mmwr.mm7102e1
_version_ 1784632716197625856
author Zambrano, Laura D.
Newhams, Margaret M.
Olson, Samantha M.
Halasa, Natasha B.
Price, Ashley M.
Boom, Julie A.
Sahni, Leila C.
Kamidani, Satoshi
Tarquinio, Keiko M.
Maddux, Aline B.
Heidemann, Sabrina M.
Bhumbra, Samina S.
Bline, Katherine E.
Nofziger, Ryan A.
Hobbs, Charlotte V.
Bradford, Tamara T.
Cvijanovich, Natalie Z.
Irby, Katherine
Mack, Elizabeth H.
Cullimore, Melissa L.
Pannaraj, Pia S.
Kong, Michele
Walker, Tracie C.
Gertz, Shira J.
Michelson, Kelly N.
Cameron, Melissa A.
Chiotos, Kathleen
Maamari, Mia
Schuster, Jennifer E.
Orzel, Amber O.
Patel, Manish M.
Campbell, Angela P.
Randolph, Adrienne G.
Murdock, Meghan
Gaspers, Mary Glas
Typpo, Katri V.
Kelley, Connor P.
Sanders, Ronald C.
Yates, Masson
Smith, Chelsea
Crane, Katheryn
Lionetti, Geraldina
Murcia-Montoya, Juliana
Zinter, Matt S.
Villarreal-Chico, Denise
Skura, Adam L.
Peralta, Harvey
Lockwood, Justin M.
Port, Emily
Carson, Imogene A.
Chatani, Brandon M.
Hussaini, Laila
Baida, Nadine
Coates, Bria M.
Rowan, Courtney M.
Stumpf, Mary
Johnston, Marla S.
Boutselis, Benjamin J.
Kucukak, Suden
Chen, Sabrina R.
Weller, Edie
Berbert, Laura
He, Jie
Flori, Heidi R.
Hume, Janet R.
Bruno, Ellen R.
Goertzen, Lexie A.
Levy, Emily R.
Behl, Supriya
Drapeau, Noelle M.
Martin, Lora
Malloch, Lacy
Sanders, Cameron
Patterson, Kayla
Dhanrajani, Anita
Hill, Shannon M.
Kietzman, Abigail
Rinehart, Valerie H.
Hoody, Lauren A.
Schwartz, Stephanie P.
Navas, Angelo G.
Bennett, Paris C.
Twinem, Nicole A.
Tomcany, Merry L.
Staat, Mary Allen
Rohlfs, Chelsea C.
Wolfe, Amber
Douglas, Rebecca L.
Phengchomphet, Kathlyn
Bickford, Megan M.
Wakefield, Lauren E.
Smallcomb, Laura
Stewart, Laura S.
Golchha, Meena
Oates, Jennifer N.
Bowens, Cindy
author_facet Zambrano, Laura D.
Newhams, Margaret M.
Olson, Samantha M.
Halasa, Natasha B.
Price, Ashley M.
Boom, Julie A.
Sahni, Leila C.
Kamidani, Satoshi
Tarquinio, Keiko M.
Maddux, Aline B.
Heidemann, Sabrina M.
Bhumbra, Samina S.
Bline, Katherine E.
Nofziger, Ryan A.
Hobbs, Charlotte V.
Bradford, Tamara T.
Cvijanovich, Natalie Z.
Irby, Katherine
Mack, Elizabeth H.
Cullimore, Melissa L.
Pannaraj, Pia S.
Kong, Michele
Walker, Tracie C.
Gertz, Shira J.
Michelson, Kelly N.
Cameron, Melissa A.
Chiotos, Kathleen
Maamari, Mia
Schuster, Jennifer E.
Orzel, Amber O.
Patel, Manish M.
Campbell, Angela P.
Randolph, Adrienne G.
Murdock, Meghan
Gaspers, Mary Glas
Typpo, Katri V.
Kelley, Connor P.
Sanders, Ronald C.
Yates, Masson
Smith, Chelsea
Crane, Katheryn
Lionetti, Geraldina
Murcia-Montoya, Juliana
Zinter, Matt S.
Villarreal-Chico, Denise
Skura, Adam L.
Peralta, Harvey
Lockwood, Justin M.
Port, Emily
Carson, Imogene A.
Chatani, Brandon M.
Hussaini, Laila
Baida, Nadine
Coates, Bria M.
Rowan, Courtney M.
Stumpf, Mary
Johnston, Marla S.
Boutselis, Benjamin J.
Kucukak, Suden
Chen, Sabrina R.
Weller, Edie
Berbert, Laura
He, Jie
Flori, Heidi R.
Hume, Janet R.
Bruno, Ellen R.
Goertzen, Lexie A.
Levy, Emily R.
Behl, Supriya
Drapeau, Noelle M.
Martin, Lora
Malloch, Lacy
Sanders, Cameron
Patterson, Kayla
Dhanrajani, Anita
Hill, Shannon M.
Kietzman, Abigail
Rinehart, Valerie H.
Hoody, Lauren A.
Schwartz, Stephanie P.
Navas, Angelo G.
Bennett, Paris C.
Twinem, Nicole A.
Tomcany, Merry L.
Staat, Mary Allen
Rohlfs, Chelsea C.
Wolfe, Amber
Douglas, Rebecca L.
Phengchomphet, Kathlyn
Bickford, Megan M.
Wakefield, Lauren E.
Smallcomb, Laura
Stewart, Laura S.
Golchha, Meena
Oates, Jennifer N.
Bowens, Cindy
author_sort Zambrano, Laura D.
collection PubMed
description
format Online
Article
Text
id pubmed-8757620
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-87576202022-01-25 Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 Zambrano, Laura D. Newhams, Margaret M. Olson, Samantha M. Halasa, Natasha B. Price, Ashley M. Boom, Julie A. Sahni, Leila C. Kamidani, Satoshi Tarquinio, Keiko M. Maddux, Aline B. Heidemann, Sabrina M. Bhumbra, Samina S. Bline, Katherine E. Nofziger, Ryan A. Hobbs, Charlotte V. Bradford, Tamara T. Cvijanovich, Natalie Z. Irby, Katherine Mack, Elizabeth H. Cullimore, Melissa L. Pannaraj, Pia S. Kong, Michele Walker, Tracie C. Gertz, Shira J. Michelson, Kelly N. Cameron, Melissa A. Chiotos, Kathleen Maamari, Mia Schuster, Jennifer E. Orzel, Amber O. Patel, Manish M. Campbell, Angela P. Randolph, Adrienne G. Murdock, Meghan Gaspers, Mary Glas Typpo, Katri V. Kelley, Connor P. Sanders, Ronald C. Yates, Masson Smith, Chelsea Crane, Katheryn Lionetti, Geraldina Murcia-Montoya, Juliana Zinter, Matt S. Villarreal-Chico, Denise Skura, Adam L. Peralta, Harvey Lockwood, Justin M. Port, Emily Carson, Imogene A. Chatani, Brandon M. Hussaini, Laila Baida, Nadine Coates, Bria M. Rowan, Courtney M. Stumpf, Mary Johnston, Marla S. Boutselis, Benjamin J. Kucukak, Suden Chen, Sabrina R. Weller, Edie Berbert, Laura He, Jie Flori, Heidi R. Hume, Janet R. Bruno, Ellen R. Goertzen, Lexie A. Levy, Emily R. Behl, Supriya Drapeau, Noelle M. Martin, Lora Malloch, Lacy Sanders, Cameron Patterson, Kayla Dhanrajani, Anita Hill, Shannon M. Kietzman, Abigail Rinehart, Valerie H. Hoody, Lauren A. Schwartz, Stephanie P. Navas, Angelo G. Bennett, Paris C. Twinem, Nicole A. Tomcany, Merry L. Staat, Mary Allen Rohlfs, Chelsea C. Wolfe, Amber Douglas, Rebecca L. Phengchomphet, Kathlyn Bickford, Megan M. Wakefield, Lauren E. Smallcomb, Laura Stewart, Laura S. Golchha, Meena Oates, Jennifer N. Bowens, Cindy MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-01-14 /pmc/articles/PMC8757620/ /pubmed/35025852 http://dx.doi.org/10.15585/mmwr.mm7102e1 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Zambrano, Laura D.
Newhams, Margaret M.
Olson, Samantha M.
Halasa, Natasha B.
Price, Ashley M.
Boom, Julie A.
Sahni, Leila C.
Kamidani, Satoshi
Tarquinio, Keiko M.
Maddux, Aline B.
Heidemann, Sabrina M.
Bhumbra, Samina S.
Bline, Katherine E.
Nofziger, Ryan A.
Hobbs, Charlotte V.
Bradford, Tamara T.
Cvijanovich, Natalie Z.
Irby, Katherine
Mack, Elizabeth H.
Cullimore, Melissa L.
Pannaraj, Pia S.
Kong, Michele
Walker, Tracie C.
Gertz, Shira J.
Michelson, Kelly N.
Cameron, Melissa A.
Chiotos, Kathleen
Maamari, Mia
Schuster, Jennifer E.
Orzel, Amber O.
Patel, Manish M.
Campbell, Angela P.
Randolph, Adrienne G.
Murdock, Meghan
Gaspers, Mary Glas
Typpo, Katri V.
Kelley, Connor P.
Sanders, Ronald C.
Yates, Masson
Smith, Chelsea
Crane, Katheryn
Lionetti, Geraldina
Murcia-Montoya, Juliana
Zinter, Matt S.
Villarreal-Chico, Denise
Skura, Adam L.
Peralta, Harvey
Lockwood, Justin M.
Port, Emily
Carson, Imogene A.
Chatani, Brandon M.
Hussaini, Laila
Baida, Nadine
Coates, Bria M.
Rowan, Courtney M.
Stumpf, Mary
Johnston, Marla S.
Boutselis, Benjamin J.
Kucukak, Suden
Chen, Sabrina R.
Weller, Edie
Berbert, Laura
He, Jie
Flori, Heidi R.
Hume, Janet R.
Bruno, Ellen R.
Goertzen, Lexie A.
Levy, Emily R.
Behl, Supriya
Drapeau, Noelle M.
Martin, Lora
Malloch, Lacy
Sanders, Cameron
Patterson, Kayla
Dhanrajani, Anita
Hill, Shannon M.
Kietzman, Abigail
Rinehart, Valerie H.
Hoody, Lauren A.
Schwartz, Stephanie P.
Navas, Angelo G.
Bennett, Paris C.
Twinem, Nicole A.
Tomcany, Merry L.
Staat, Mary Allen
Rohlfs, Chelsea C.
Wolfe, Amber
Douglas, Rebecca L.
Phengchomphet, Kathlyn
Bickford, Megan M.
Wakefield, Lauren E.
Smallcomb, Laura
Stewart, Laura S.
Golchha, Meena
Oates, Jennifer N.
Bowens, Cindy
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
title Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
title_full Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
title_fullStr Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
title_full_unstemmed Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
title_short Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
title_sort effectiveness of bnt162b2 (pfizer-biontech) mrna vaccination against multisystem inflammatory syndrome in children among persons aged 12–18 years — united states, july–december 2021
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757620/
https://www.ncbi.nlm.nih.gov/pubmed/35025852
http://dx.doi.org/10.15585/mmwr.mm7102e1
work_keys_str_mv AT zambranolaurad effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT newhamsmargaretm effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT olsonsamantham effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT halasanatashab effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT priceashleym effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT boomjuliea effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT sahnileilac effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT kamidanisatoshi effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT tarquiniokeikom effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT madduxalineb effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT heidemannsabrinam effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT bhumbrasaminas effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT blinekatherinee effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT nofzigerryana effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT hobbscharlottev effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT bradfordtamarat effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT cvijanovichnataliez effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT irbykatherine effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT mackelizabethh effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT cullimoremelissal effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT pannarajpias effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT kongmichele effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT walkertraciec effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT gertzshiraj effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT michelsonkellyn effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT cameronmelissaa effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT chiotoskathleen effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT maamarimia effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT schusterjennifere effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT orzelambero effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT patelmanishm effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT campbellangelap effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT randolphadrienneg effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT murdockmeghan effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT gaspersmaryglas effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT typpokatriv effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT kelleyconnorp effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT sandersronaldc effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT yatesmasson effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT smithchelsea effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT cranekatheryn effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT lionettigeraldina effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT murciamontoyajuliana effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT zintermatts effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT villarrealchicodenise effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT skuraadaml effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT peraltaharvey effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT lockwoodjustinm effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT portemily effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT carsonimogenea effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT chatanibrandonm effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT hussainilaila effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT baidanadine effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT coatesbriam effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT rowancourtneym effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT stumpfmary effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT johnstonmarlas effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT boutselisbenjaminj effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT kucukaksuden effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT chensabrinar effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT welleredie effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT berbertlaura effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT hejie effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT floriheidir effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT humejanetr effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT brunoellenr effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT goertzenlexiea effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT levyemilyr effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT behlsupriya effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT drapeaunoellem effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT martinlora effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT mallochlacy effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT sanderscameron effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT pattersonkayla effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT dhanrajanianita effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT hillshannonm effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT kietzmanabigail effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT rinehartvalerieh effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT hoodylaurena effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT schwartzstephaniep effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT navasangelog effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT bennettparisc effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT twinemnicolea effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT tomcanymerryl effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT staatmaryallen effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT rohlfschelseac effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT wolfeamber effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT douglasrebeccal effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT phengchomphetkathlyn effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT bickfordmeganm effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT wakefieldlaurene effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT smallcomblaura effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT stewartlauras effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT golchhameena effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT oatesjennifern effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021
AT bowenscindy effectivenessofbnt162b2pfizerbiontechmrnavaccinationagainstmultisysteminflammatorysyndromeinchildrenamongpersonsaged1218yearsunitedstatesjulydecember2021